ELAINE LY: Open Payments
NPI 1265922496 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 36 payments from 17 companies in 2025. Trend: 2023 $21 · 2024 $404 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $111 |
| Sage Therapeutics, LLC | 3 | $72 |
| SHIELD THERAPEUTICS INC | 4 | $68 |
| Evofem Biosciences, Inc. | 6 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Exeltis, USA Inc. | 3 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $40 |
| Eisai Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: MYFEMBREE, ZURZUVAE, ACCRUFER, Phexxi, Mirena, SLYND, Lenvima, ELAHERE.
Industry payments across TX — which companies pay providers there.
